Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy
Abbott’s Exact Sciences acquisition raises leverage, leaving Medical Devices’ 8% growth and 33.9% margin to carry cash flow until…
PV Research 1 clickNASDAQ
Exact Sciences CORP
EXAS
1 story
Delisted Jul 31
Get EXAS news in Claude, ChatGPT or your own code. See plans
PV Research 1 clickInvestor Letters
Letters that discuss EXAS.
Tickers on this page
Companies the stories above are also about, besides EXAS.
